Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Irwig

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The Lancet. Diabetes & Endocrinology|April 17, 2016
Testosterone therapy for transgender menMichael S Irwig
Reviews in Endocrine & Metabolic Disorders|August 4, 2018
Cardiovascular health in transgender peopleMichael S Irwig
Andrology|October 29, 2021
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effectsMichael S Irwig
Current Opinion in Endocrinology, Diabetes, and Obesity|April 15, 2015
Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopeciaMichael S Irwig
Journal of General Internal Medicine|July 5, 2022
Battling the Testosterone Clinics and WebsitesMichael S Irwig
Sexual Medicine Reviews|January 1, 2014
Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger MenMichael S Irwig
The Journal of Clinical Endocrinology and Metabolism|September 19, 2020
Which reference range should we use for transgender and gender diverse patients?Michael S Irwig
Andrology|November 24, 2021
The growing and interdisciplinary field of transgender healthMichael S Irwig
The Journal of Clinical Psychiatry|September 4, 2012
Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effectsMichael S Irwig
Current Opinion in Endocrinology, Diabetes, and Obesity|January 29, 2014
Male hypogonadism and skeletal healthMichael S Irwig
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The Lancet. Diabetes & Endocrinology|April 17, 2016
Testosterone therapy for transgender menMichael S Irwig
Reviews in Endocrine & Metabolic Disorders|August 4, 2018
Cardiovascular health in transgender peopleMichael S Irwig
Andrology|October 29, 2021
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effectsMichael S Irwig
Current Opinion in Endocrinology, Diabetes, and Obesity|April 15, 2015
Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopeciaMichael S Irwig
Journal of General Internal Medicine|July 5, 2022
Battling the Testosterone Clinics and WebsitesMichael S Irwig
Sexual Medicine Reviews|January 1, 2014
Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger MenMichael S Irwig
The Journal of Clinical Endocrinology and Metabolism|September 19, 2020
Which reference range should we use for transgender and gender diverse patients?Michael S Irwig
Andrology|November 24, 2021
The growing and interdisciplinary field of transgender healthMichael S Irwig
The Journal of Clinical Psychiatry|September 4, 2012
Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effectsMichael S Irwig
Current Opinion in Endocrinology, Diabetes, and Obesity|January 29, 2014
Male hypogonadism and skeletal healthMichael S Irwig
Pageof 6